A new therapeutic assessment score for advanced hepatocellular carcinoma patients receiving hepatic arterial infusion chemotherapy.
about
Effectiveness of PIVKA-II in the detection of hepatocellular carcinoma based on real-world clinical dataClinical application of protein induced by vitamin K antagonist-II as a biomarker in hepatocellular carcinoma.Evaluation of the "assessment for continuous treatment with hepatic arterial infusion chemotherapy" scoring system in patients with advanced hepatocellular carcinoma.Treatment strategies for advanced hepatocellular carcinoma: Sorafenib hepatic arterial infusion chemotherapy
P2860
A new therapeutic assessment score for advanced hepatocellular carcinoma patients receiving hepatic arterial infusion chemotherapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A new therapeutic assessment s ...... rterial infusion chemotherapy.
@ast
A new therapeutic assessment s ...... rterial infusion chemotherapy.
@en
type
label
A new therapeutic assessment s ...... rterial infusion chemotherapy.
@ast
A new therapeutic assessment s ...... rterial infusion chemotherapy.
@en
prefLabel
A new therapeutic assessment s ...... rterial infusion chemotherapy.
@ast
A new therapeutic assessment s ...... rterial infusion chemotherapy.
@en
P2093
P2860
P1433
P1476
A new therapeutic assessment s ...... rterial infusion chemotherapy.
@en
P2093
Isao Hidaka
Isao Sakaida
Issei Saeki
Koichi Uchida
Naoki Yamamoto
Norikazu Tanabe
Shuji Terai
Takahiro Yamasaki
Takuya Iwamoto
Taro Takami
P2860
P304
P356
10.1371/JOURNAL.PONE.0126649
P407
P577
2015-05-20T00:00:00Z